These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 222641)

  • 21. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcellular localization of cryptic prolactin receptors in mammary tumor cells.
    Costlow ME; Rodgers QE
    Exp Cell Res; 1986 Mar; 163(1):159-64. PubMed ID: 3002826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of relationship between prolactin binding and growth rate of carcinogen-induced mammary tumors or circulating levels of mammotropic hormones in rats.
    Nagasawa H; Yanai R; Shiota K; Nakajima Y
    Gan; 1980 Apr; 71(2):271-2. PubMed ID: 6259012
    [No Abstract]   [Full Text] [Related]  

  • 25. The characteristic binding of catechol estrogens to estrogen receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Tanaka T; Katoh M; Kubodera A
    Steroids; 1986; 48(5-6):361-8. PubMed ID: 2832979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
    Asselin J; Melançon R; Moachon G; Bélanger A
    Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
    [No Abstract]   [Full Text] [Related]  

  • 27. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol binding by intact cells isolated from DMBA-induced mammary tumors of the rat.
    Capuco AV; Tseng MT
    Steroids; 1981 Jun; 37(6):649-62. PubMed ID: 6794191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic inhibitors increase prolactin binding to cultured mammary tumor cells.
    Costlow M; Hample A
    Biochem Biophys Res Commun; 1980 Jan; 92(1):213-20. PubMed ID: 6243935
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro transformation of mouse mammary epithelial cells grown serum-free inside collagen gels.
    Guzman RC; Osborn RC; Bartley JC; Imagawa W; Asch BB; Nandi S
    Cancer Res; 1987 Jan; 47(1):275-80. PubMed ID: 3098407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and assay of progesterone-binding components in DMBA-induced rat mammary carcinoma tissue after progesterone administration.
    Geier A; Shelef M; Beery R; Lunenfeld B
    J Steroid Biochem; 1983 Sep; 19(3):1301-7. PubMed ID: 6413784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin.
    Vignon F; Rochefort H
    Endocrinology; 1976 Mar; 98(3):722-9. PubMed ID: 177271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin receptors in explant cultures of carcinogen-induced rat mammary tumors.
    Gandilhon P; Melancon R; Gandilhon F; Djiane J; Kelly PA
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):561-6. PubMed ID: 6305669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin receptors in cultured rat mammary tumor cells. Unmasking of cell surface receptors by energy depletion.
    Costlow ME; Hample A
    J Biol Chem; 1982 Jun; 257(12):6971-7. PubMed ID: 6282826
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML; Levy J; Rosen JM
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on insulin, prolactin, progesterone, and estradiol on DNA synthesis in organ culture of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Pasteels JL; Heuson JC; Heuson-Stiennon J; Legros N
    Cancer Res; 1976 Jul; 36(7 PT 1):2162-70. PubMed ID: 819126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER; Kledzik G; Marshall S; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM; Friesen HG
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct placental lactogen and prolactin (lactogen) receptors in bovine endometrium.
    Galosy SS; Gertler A; Elberg G; Laird DM
    Mol Cell Endocrinol; 1991 Jul; 78(3):229-36. PubMed ID: 1663880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.